Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases
2018-04-18 15:57
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment
2018-04-17 15:03
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
2018-02-15 16:35
NeuroVive Decides on a Rights Issue for Continued Drug Development
2018-02-15 16:18
NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project
2018-01-29 21:05
NeuroVive to Present at the 10th Annual Biotech Showcase Conference
2018-01-03 16:10
NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333
2017-12-11 18:56
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)
2017-11-30 19:51
NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone
2017-11-30 16:26
NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference
2017-11-15 16:48
NeuroVive Board Chair Resigns, New Chair Elected
2017-11-07 15:55
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million
2017-11-03 16:33
NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development
2017-10-31 16:32
NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research
2017-10-18 15:05
NeuroVive's Collaborator, the Children's Hospital of Philadelphia Awarded NIH Grant to Study NVP015 Against Chemical Threats
2017-10-06 05:44
NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project
2017-06-01 19:52
NeuroVive Pharmaceutical AB Interim Report January - March 2017
2017-05-18 15:18
NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm
2017-05-02 11:51
NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects
2017-04-20 15:05
1
2